Efficacy News and Research

RSS
India's DBT, Bharat Biotech announce positive Phase III clinical trial results of rotavirus vaccine

India's DBT, Bharat Biotech announce positive Phase III clinical trial results of rotavirus vaccine

Research findings may pave way to new treatment for Alzheimer's disease in humans

Research findings may pave way to new treatment for Alzheimer's disease in humans

COSIRA trial: Enrollment complete for assessing Neovasc Reducer in refractory angina patients

COSIRA trial: Enrollment complete for assessing Neovasc Reducer in refractory angina patients

Scientists make novel discoveries concerning current vaccine against whooping cough

Scientists make novel discoveries concerning current vaccine against whooping cough

TYRX's AIGISRx Antibacterial Envelope reduces CIED infection rates by more than 90%

TYRX's AIGISRx Antibacterial Envelope reduces CIED infection rates by more than 90%

Breo Ellipta gets FDA approval for treatment of airflow obstruction in patients with COPD

Breo Ellipta gets FDA approval for treatment of airflow obstruction in patients with COPD

Study results suggest that CNL and aCML patients could be treated with FDA-approved drugs

Study results suggest that CNL and aCML patients could be treated with FDA-approved drugs

John Theurer to host 9th annual neuro-oncology symposium on May 17

John Theurer to host 9th annual neuro-oncology symposium on May 17

FDA approves Novartis' Ilaris for treatment of active systemic juvenile idiopathic arthritis

FDA approves Novartis' Ilaris for treatment of active systemic juvenile idiopathic arthritis

InSite Vision starts patient enrollment in confirmatory Phase 3 clinical trial of BromSite

InSite Vision starts patient enrollment in confirmatory Phase 3 clinical trial of BromSite

Mathematical model with prognostic factors predicts treatment effect with bevacizumab in colorectal cancer patients

Mathematical model with prognostic factors predicts treatment effect with bevacizumab in colorectal cancer patients

More work needed to understand use of nanosilver, say researchers

More work needed to understand use of nanosilver, say researchers

Antitumor medication from natural origins on the rise

Antitumor medication from natural origins on the rise

TRACK-HD study: A set of tests could help identify progression of Huntington's disease

TRACK-HD study: A set of tests could help identify progression of Huntington's disease

FDA accepts Merck's BLA for investigational ragweed pollen sublingual allergy immunotherapy tablet

FDA accepts Merck's BLA for investigational ragweed pollen sublingual allergy immunotherapy tablet

New technique can lead to effective use of nanoparticles as drug delivery system

New technique can lead to effective use of nanoparticles as drug delivery system

Protein tumor necrosis factor-alpha is a powerful weapon to control cancer

Protein tumor necrosis factor-alpha is a powerful weapon to control cancer

New VLP vaccine candidate produced for H7N9 virus

New VLP vaccine candidate produced for H7N9 virus

Cell Medica treats first pediatric patient in ASPIRE Trial

Cell Medica treats first pediatric patient in ASPIRE Trial

Peripheral neuropathic pain patch treatments: an interview with Anne Hodgkins, Astellas Pharma

Peripheral neuropathic pain patch treatments: an interview with Anne Hodgkins, Astellas Pharma

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.